Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer

Completed · Phase 2 · Has a placebo group

Conditions studied: Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage II Prostate Cancer, Stage III Prostate Cancer

In brief

This randomized phase II trial studies how well different doses of lycopene work in treating patients undergoing radical prostatectomy for prostate cancer. The use of lycopene, a substance found in tomatoes, may keep prostate cancer from growing or coming back after surgery.

Key facts

Study ID

NCT00450749

Run by

National Cancer Institute (NCI)

People needed

10

Starts

2008-02-01

Expected to finish

2010-05-01

Last updated by the study team

2019-12-18

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• M D Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.